Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Operating Expenses (2018 - 2025)

Health Catalyst (HCAT) has disclosed Operating Expenses for 8 consecutive years, with $55.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses rose 15.92% year-over-year to $55.3 million, compared with a TTM value of $239.3 million through Sep 2025, up 7.93%, and an annual FY2024 reading of $210.6 million, down 18.61% over the prior year.
  • Operating Expenses was $55.3 million for Q3 2025 at Health Catalyst, down from $75.3 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $77.7 million in Q3 2022 and bottomed at $47.7 million in Q3 2024.
  • Average Operating Expenses over 5 years is $62.7 million, with a median of $61.9 million recorded in 2021.
  • The sharpest move saw Operating Expenses surged 73.03% in 2021, then decreased 27.23% in 2023.
  • Year by year, Operating Expenses stood at $75.6 million in 2021, then fell by 10.32% to $67.8 million in 2022, then fell by 6.65% to $63.3 million in 2023, then fell by 17.54% to $52.2 million in 2024, then rose by 6.0% to $55.3 million in 2025.
  • Business Quant data shows Operating Expenses for HCAT at $55.3 million in Q3 2025, $75.3 million in Q2 2025, and $56.4 million in Q1 2025.